Epidemiology of Systemic Mycoses in the COVID-19 Pandemic
Open Access
- 13 July 2021
- journal article
- review article
- Published by MDPI AG in Journal of Fungi
- Vol. 7 (7), 556
- https://doi.org/10.3390/jof7070556
Abstract
The physiopathologic characteristics of COVID-19 (high levels of inflammatory cytokines and T-cell reduction) promote fungal colonization and infection, which can go unnoticed because the symptoms in both diseases are very similar. The objective of this work was to study the current epidemiology of systemic mycosis in COVID-19 times. A literature search on the subject (January 2020–February 2021) was performed in PubMed, Embase, Cochrane Library, and LILACS without language restrictions. Demographic data, etiological agent, risk factors, diagnostic methods, antifungal treatment, and fatality rate were considered. Eighty nine publications were found on co-infection by COVID-19 and pneumocystosis, candidiasis, aspergillosis, mucormycosis, coccidioidomycosis, or histoplasmosis. In general, the co-infections occurred in males over the age of 40 with immunosuppression caused by various conditions. Several species were identified in candidiasis and aspergillosis co-infections. For diagnosis, diverse methods were used, from microbiological to molecular. Most patients received antifungals; however, the fatality rates were 11–100%. The latter may result because the clinical picture is usually attributed exclusively to SARS-CoV-2, preventing a clinical suspicion for mycosis. Diagnostic tests also have limitations beginning with sampling. Therefore, in the remainder of the pandemic, these diagnostic limitations must be overcome to achieve a better patient prognosis.Keywords
This publication has 111 references indexed in Scilit:
- Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatmentCurrent Opinion in Infectious Diseases, 2018
- Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort studyThe Lancet Respiratory Medicine, 2018
- Influenza-associated Aspergillosis in Critically Ill PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Invasive Aspergillosis Associated With Severe Influenza InfectionsOpen Forum Infectious Diseases, 2016
- Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective studyIntensive Care Medicine, 2012
- Invasive Aspergillosis Complicating Pandemic Influenza A (H1N1) Infection in Severely Immunocompromised PatientsClinical Infectious Diseases, 2011
- Isolation of Aspergillus in three 2009 H1N1 influenza patientsInfluenza and Other Respiratory Viruses, 2011
- Pulmonary pathology of severe acute respiratory syndrome in TorontoLaboratory Investigation, 2005
- Fatal Aspergillosis in a Patient with SARS Who Was Treated with CorticosteroidsThe New England Journal of Medicine, 2003
- Molecular Approaches to Diagnosing and Managing Infectious Diseases: Practicality and CostsEmerging Infectious Diseases, 2001